scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1872-034X.2010.00720.X |
P8608 | Fatcat ID | release_wlantpcct5e4pdojshf4i5a634 |
P698 | PubMed publication ID | 20849431 |
P50 | author | Fumitaka Suzuki | Q114923480 |
Masahiro Kobayashi | Q114923755 | ||
Yoshiyuki Suzuki | Q114923935 | ||
Yasuji Arase | Q114924322 | ||
Satoshi Saito | Q114924602 | ||
Tetsuya Hosaka | Q56223851 | ||
Norio Akuta | Q87747459 | ||
Yusuke Kawamura | Q90407021 | ||
Hitomi Sezaki | Q92198438 | ||
Kenji Ikeda | Q114433562 | ||
Hiromitsu Kumada | Q114433568 | ||
P2093 | author name string | Yuya Seko | |
Miharu Hirakawa | |||
Norihiro Imai | |||
P2860 | cites work | Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma | Q34225751 |
Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus | Q44314372 | ||
Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial | Q45737388 | ||
P433 | issue | 12 | |
P921 | main subject | Hepatitis C virus | Q708693 |
P304 | page(s) | 1168-1175 | |
P577 | publication date | 2010-09-16 | |
P1433 | published in | Hepatology Research | Q15752035 |
P1476 | title | Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer | |
P478 | volume | 40 |
Q38134777 | A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma |
Q45351713 | Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis |
Q37972807 | Adjuvant therapy after curative treatment for hepatocellular carcinoma |
Q34101953 | Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review |
Q36436294 | Current status of multimodal & combination therapy for hepatocellular carcinoma |
Q40051671 | Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma. |
Q50527907 | Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. |
Search more.